Patents
Patents for C07B 59 - Introduction of isotopes of elements into organic compounds (2,678)
05/2005
05/19/2005WO2005045850A2 Radioactive arsenic triiodide and use thereof for radioactive markings
05/19/2005WO2005044758A1 Process for producing radioactive-fluorine-labeled compound
05/12/2005WO2005042441A1 Method and apparatus for the use of [11c] carbon monixide in labeling synthesis by photo-initiated carbonylation
05/11/2005EP1337532B1 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
05/06/2005CA2782783A1 Fused heterocyclic compounds
04/2005
04/28/2005WO2005037853A2 Side chain deuterated amino acids and methods of use
04/28/2005WO2005037737A1 Method for the production of [18f] fluoride-marked aromatic l-amino acids
04/28/2005US20050089471 A reaction product of an antibody, protein, biomolecule, polysaccharide, or peptidomimetic, a luminescent dye, radionuclide, near infrared dye, a magnetically active isotope, a superparamagnetic particle, or a metal ion, and a linker moiety; diagnosis and monitoring of inflammatory diseases
04/28/2005US20050089470 Labeled peptides for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
04/21/2005US20050084452 Deuterated hydrogen in protein, radioactive carbon or nitrogen; bioassay of accurate analyzing the structure of the target high molecular weight protein; producing stable isotope-labeled fumaric acid, tartaric acid through esterification, oxidation, hydrolysis; chemical peptide synthesis
04/19/2005CA2138150C 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides
04/07/2005WO2005030677A1 Process for producing radioactive fluorine compound
04/07/2005WO2005030676A1 Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds
04/07/2005CA2540827A1 Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds
03/2005
03/29/2005US6872381 Such as 1-(5-chloro-2-(2-((2R)-4-(4-fluoro-18F-benzyl)-2-methylpiperazin-1-yl)-2 -oxoethoxy)phenyl)urea for binding chemokine receptors in brain tissue; tomography
03/02/2005EP0836609B1 Method and device for synthesising labelled compounds
02/2005
02/17/2005WO2005014479A2 Process for preparing radiolabeled compounds
02/17/2005CA2536659A1 Process
02/03/2005CA2783275A1 Stable radiopharmaceutical compositions and methods for their preparation
02/03/2005CA2533416A1 Heavy-hydrogenated norbornyl (meth)acrylates, process for producing them, polymers thereof and optical members
02/03/2005CA2533415A1 Heavy-hydrogenated (meth)acrylates, process for producing them, polymers thereof and optical members
01/2005
01/27/2005WO2004098650A3 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
01/27/2005US20050020679 Enzyme inhibitors for anandamide transporter and pharmacological use with urea, amide, thiourea or other groups
01/20/2005CA2532038A1 Compositions and methods for stable isotope labelling of biological compounds
01/19/2005EP1181271B1 Naphthalene ureas as glucose uptake enhancers
01/19/2005CN1185252C Somatostatin peptides
01/19/2005CN1185210C Use of naphthalene-carboxylic acid for preparing a medicament used for treating diseases characterized by amyloid aggregation sedimentation
01/12/2005EP1495031A1 Labeled oxazinocarbazoles as diagnostic agents
12/2004
12/29/2004CN1182116C Mutilin derivatives and their use as antibacterials
12/29/2004CN1182111C Nitroso compound and use of it as spin catching agent
12/28/2004US6835371 Diagnostic and therapeutic piperazine and piperidine compounds and process
12/22/2004EP1487763A2 Use of microfabricated devices for radiosynthesis
12/22/2004EP1487762A1 Radiofluorination methods
12/16/2004WO2004108636A2 Isotopically labeled chemically stable reagents and process for the synthesis thereof
12/16/2004US20040253180 Deuterated nifedipine and penicillins; improved bioavailability
12/15/2004EP0988263B1 Process for the production of radioiodinated neuroreceptor agents
12/02/2004US20040242887 Hypotonic bladder diseases
12/02/2004US20040242852 Bifunctional chelating agent for actinium
12/02/2004US20040242652 Beta benzyloxyaspartate derivatives with amino group on benzene ring
12/01/2004EP1480739A2 Apparatus for synthesis of radiolabeled compounds
11/2004
11/30/2004US6824982 High-throughput-screening method for determining enantioselectivity
11/30/2004US6824760 Imaging agents, precursors thereof and methods of manufacture
11/25/2004US20040236085 Solid-phase nucleophilic fluorination
11/25/2004US20040235910 Mutilin derivatives and their use as antibacterials
11/18/2004WO2004100490A2 Device and method for the fluorination of nucleophiles
11/18/2004WO2004098650A2 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
11/18/2004US20040230064 Novel labeled resiniferatoxin derivatives
11/16/2004US6818200 Modification of the molecular structure of dihydropyridine family drug containing one or more hydrogen atoms by deuterating one or more hydrogen atoms to deuterium atoms; improved activity over the known drug
11/11/2004US20040225121 Labeling using deuterium, tritium with catalyst
11/10/2004EP1474177A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
11/04/2004DE10316965A1 New technetium-labeled fatty acids based on nitrilo-tris-(alkanethiolato) complexes, useful as stable radioactive tracers for diagnostic imaging of the myocardium
10/2004
10/26/2004CA2185306C Radio-detection method of oxygenation reaction
10/20/2004CN1538876A Novel catalytic formulation and its preparation method
10/19/2004WO2004069773A1 Irreversible caspase-3 inhibitors as active site probes
10/19/2004US6806281 Treatment of cocaine abuse, parkinson's disease
10/19/2004CA2514441A1 Irreversible caspase-3 inhibitors as active site probes
10/13/2004EP1173184B1 para-BORONOPHENYLALANINE COMPLEXES WITH FRUCTOSE AND RELATED CARBOHYDRATES AND POLYOLS
10/13/2004EP0876402B1 Growth hormone secretagogue receptor family
10/07/2004US20040197257 reacting carbon dioxide isotope in gas mixture ; forming, trapping carbon monoxide in complex; using pressurized chemical reactor
09/2004
09/29/2004EP0912533B1 Alkylaminobenzothiazole and -benzoxazole derivatives
09/23/2004WO2004080492A1 Methods of radiofluorination of biologically active vectors
09/23/2004US20040186312 Solid-phase electrophilic fluorination
09/23/2004US20040186136 E.g., mono-, poly- or perdeuteriated tolperisone and eperisone; appreciably better pharmacokinetic and/or pharmacodynamic properties than the undeuterated compounds; muscular disorders; muscle relaxants (skeletal); antispasmodic agents; vasodilation
09/23/2004US20040184991 Ac-HEHA and related compounds, methods of synthesis and methods of use
09/23/2004CA2518889A1 Methods of radiofluorination of biologically active vectors
09/21/2004US6794522 Labeling organic compounds with deuterium and tritium using specific catalysts based on group 8 metals containing pentamethylcyclopentadiene ligand; deuterated tetrahydrofuran or diethyl ether for example
09/15/2004EP1457482A1 Stable isotope-labeled amino acid, method of integrating the same into target protein, method of nmr structural analysis of protein and process for producing site-selective stable isotope-labeled fumaric acid and tartaric acid
09/15/2004EP1165834B1 High throughput screening method for determining enantioselectivity
09/14/2004US6790843 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof
09/08/2004CN1527823A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
09/01/2004EP0674530B1 Radiolabeled polyhydric phenol compounds
08/2004
08/31/2004US6784193 Mutilin derivatives and their use as antibacterials
08/26/2004US20040167330 Suitable targeting moieties are monoclonal antibodies, their fragments and recombinant derivatives such as single chain antibodies, diabodies, triabodies, humanized, human or chimeric variants but also peptides, aptamers, spiegelmers, nucleotides, anti sense oligomers
08/12/2004WO2004010846A3 Design and synthesis of renal dipeptidase inhibitors
08/11/2004CN1520315A Solid-phase nucleophilic fluorination
07/2004
07/29/2004DE19949237B4 Vorstufenverbindung für Radiodiagnostika und Verfahren zu ihrer Herstellung Precursor for radio diagnostics and process for their preparation
07/28/2004CN1516684A Deuterated N-substituted and alpha-substituted diphenylalkoxy acetic acid amino alkyl esters and medicaments containing these compounds
07/27/2004US6767715 Nitroso compounds and their use as spin traps
07/22/2004WO2004060831A1 Method of deuterization
07/22/2004CA2511885A1 Method of deuteration
07/21/2004EP1438299A1 Bifunctional chelating agent for actinium
07/08/2004WO2004056725A1 Solid-phase preparation of 18f-labelled amino acids
07/08/2004WO2004056724A1 Deuterated catecholamine derivatives and medicaments comprising said compounds
07/08/2004DE19744003B4 Kontrastmittel für das Infarkt- und Nekroseimaging Contrast agents for infarction and necrosis
07/01/2004WO2003104430A3 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
07/01/2004DE10261807A1 Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel Deuterated catecholamine derivatives and pharmaceutical compositions containing them
06/2004
06/15/2004US6749830 Injecting sample comprising a precursor chemical compound, into injection loop of a high performance liquid chromatograph (hplc); injecting radiolabeling reagent into loop to react and form radiolabeled compound, isolating
06/15/2004CA2086426C Process for the preparation of transition metal nitrido complexes
06/03/2004WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring
06/03/2004CA2506010A1 A method for deuteration of a heterocyclic ring
05/2004
05/27/2004WO2004043496A1 Fluorquinolines labelled with fluorine-18
05/19/2004EP1418950A1 Solid-phase nucleophilic fluorination
05/13/2004WO2004029006A3 Process for the preparation of fluorohaloalkanes
05/13/2004US20040091422 Aminophosphinic acid derivatives were synthesized as potential inhibitors of renal dipeptidase, an enzyme overexpressed in benign and malignant colon tumors. Several compounds showed potent enzyme-inhibitory activity. These
05/02/2004WO2004011400A1 Method of deuterating aromatic ring
04/2004
04/14/2004EP1406879A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents
04/14/2004EP1406835A1 Method and apparatus for production and use of ?11 c] carbon monoxide in labeling synthesis
04/08/2004WO2004029006A2 Process for the preparation of fluorohaloalkanes
04/01/2004US20040062714 Synthesis of 17F labeled fluoroalkanes
03/2004
03/24/2004EP1399401A2 Solid-phase electrophilic fluorination
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 27